- Home
- FATE vs PHX Comparison
FATE vs PHX Comparison
Compare FATE & PHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- PHX
- Stock Information
- Founded
- FATE 2007
- PHX 1926
- Country
- FATE United States
- PHX United States
- Employees
- FATE N/A
- PHX N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- PHX Oil & Gas Production
- Sector
- FATE Health Care
- PHX Energy
- Exchange
- FATE Nasdaq
- PHX Nasdaq
- Market Cap
- FATE 108.2M
- PHX 148.4M
- IPO Year
- FATE 2013
- PHX N/A
- Fundamental
- Price
- FATE $0.94
- PHX $3.87
- Analyst Decision
- FATE Hold
- PHX Buy
- Analyst Count
- FATE 9
- PHX 1
- Target Price
- FATE $5.50
- PHX $4.30
- AVG Volume (30 Days)
- FATE 3.4M
- PHX 73.6K
- Earning Date
- FATE 03-05-2025
- PHX 03-12-2025
- Dividend Yield
- FATE N/A
- PHX 4.08%
- EPS Growth
- FATE N/A
- PHX N/A
- EPS
- FATE N/A
- PHX 0.06
- Revenue
- FATE $13,631,000.00
- PHX $34,571,064.00
- Revenue This Year
- FATE N/A
- PHX N/A
- Revenue Next Year
- FATE N/A
- PHX $28.73
- P/E Ratio
- FATE N/A
- PHX $65.50
- Revenue Growth
- FATE N/A
- PHX N/A
- 52 Week Low
- FATE $0.87
- PHX $3.01
- 52 Week High
- FATE $7.70
- PHX $4.24
- Technical
- Relative Strength Index (RSI)
- FATE 37.74
- PHX 47.41
- Support Level
- FATE $0.87
- PHX $4.00
- Resistance Level
- FATE $1.03
- PHX $4.03
- Average True Range (ATR)
- FATE 0.12
- PHX 0.16
- MACD
- FATE -0.01
- PHX -0.02
- Stochastic Oscillator
- FATE 13.12
- PHX 38.33
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About PHX PHX Minerals Inc.
PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The revenues is derived from royalties granted from the production and sale of natural gas, oil and NGL, and the remaining portion of its revenues is derived from the production and sale of natural gas, oil and NGL on its working interests.